Paul Emery

University of Leeds — United Kingdom

Medicine · Health Sciences

158h-index127.0kcitations1.6kworks5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(1003), Systemic Lupus Erythematosus Research(471), Autoimmune and Inflammatory Disorders Research(311), Spondyloarthritis Studies and Treatments(252), Chronic Lymphocytic Leukemia Research(192)

Publications1.6k total

Living with palindromic rheumatism: a qualitative interview study
Rheumatology Advances in Practice·2025Open Access
The <i>PTPN22</i> R620W polymorphism is associated with inclusion body myositis: data from the UKMyoNet study
Lara D. Veeken·2025Open Access
Ultrasound-detected inflammation and structural changes in the joints, tendons and entheses of patients with cancer who developed arthritis or arthralgia after exposure to immune checkpoint inhibitors
RMD Open·2025Open Access
Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up
Lara D. Veeken·2025Open Access
Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis
Annals of the Rheumatic Diseases·2025· 2 citedOpen Access
PASDAS test–retest reliability in early, untreated PsA: data from the GOLMePsA clinical trial
Lara D. Veeken·2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial
The Lancet Rheumatology·2025· 3 cited
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study
Seminars in Arthritis and Rheumatism·2025Open Access
Integrating handheld ultrasound in rheumatology: A review of benefits and drawbacks
Best Practice & Research Clinical Rheumatology·2025· 1 cited
Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study
The Lancet Rheumatology·2025· 5 citedOpen Access
POS1293 REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS
Annals of the Rheumatic Diseases·2025Open Access
POS0545 Retrospective analysis of cardiovascular and malignancy risk factors in real world JAK inhibitor cohort and the effects of UK regulatory agency guidance cautioning JAK inhibitor use on prescribing
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
POS1299 ULTRASOUND JOINT, TENDON AND ENTHESEAL INFLAMMATION IN CANCER PATIENTS WHO DEVELOP ARTHRITIS OR ARTHRALGIA AFTER EXPOSURE TO IMMUNE CHECKPOINT INHIBITORS: RESULTS OF A MULTI-NATIONAL COHORT STUDY
Annals of the Rheumatic Diseases·2025Open Access
OP0151 UPREGULATION OF TYPE 1 INTERFERON STIMULATED GENES IN CIRCULATING INNATE IMMUNE CELLS PRECEDES THE ONSET OF SUBCLINICAL SYNOVITIS IN ANTI-CCP+ AT-RISK INDIVIDUALS WHO IMMINENTLY PROGRESS TO RHEUMATOID ARTHRITIS.
Annals of the Rheumatic Diseases·2025· 1 citedOpen Access
POS0325 RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT
Annals of the Rheumatic Diseases·2025Open Access
POS0472 Quantitative MRI tenosynovitis volume explains the association between tendon involvement and progression to clinical arthritis in anti-CCP+ at risk individuals
Annals of the Rheumatic Diseases·2025Open Access
OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY
Annals of the Rheumatic Diseases·2025· 3 citedOpen Access
RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT
The Journal of Rheumatology·2025Open Access
P158 Effectiveness and safety of rituximab and cyclophosphamide for the treatment of Sjögren’s disease-related peripheral neuropathy: a retrospective cohort study  
Lara D. Veeken·2025Open Access
OA09 Progression of foot involvement in individuals at risk of rheumatoid arthritis: findings from a UK cohort study
Lara D. Veeken·2025Open Access
page 1 of 81Next →

Frequent Co-authors

Daniel Aletaha(12), Désirée van der Heijde(11), Bernard Combe(10), Robert Landewé(10), Maxime Dougados(9), Josef S Smolen(9), Ronald van Vollenhoven(8), Edward Keystone(8), Maxime Dougados(8), Tore K Kvien(8), Karel Pavelká(8), Gerd R Burmester(7), Josef S Smolen(7), Ferdinand C. Breedveld(6), Iain B. McInnes(6), Maarten de Wit(6), E. Martín‐Mola(6), Joachim Sieper(6), Laure Gossec(5), Juan J. Gómez‐Reino(5)